Journal of Clinical Virology

Article	Citations
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms	187
Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2	169
Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis	122
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection	114
Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?	97
Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria	96
Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutrali	94
Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus	87
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect	77
Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection	64
Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis	63
Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-2	58
Comparison of SARS-CoV-2 serological tests with different antigen targets	55
Recommendations for the introduction of metagenomic next-generation sequencing in clinical virology, part II: bioinformatic analysis and reporting	54
Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure	54
A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance	53
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody	52
Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis	50
Saliva specimens for detection of severe acute respiratory syndrome coronavirus 2 in Kuwait: A cross-sectional study	49
Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test	49
Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay	48
SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus	47
Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus.	44
Development of a point-of-care test to detect SARS-CoV-2 from saliva which combines a simple RNA extraction method with colorimetric reverse transcription loop-mediated isothermal amplification detect	44
Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort	44

Single-step RT-PCR assay for dual genotyping of GI and GII norovirus strains	43
Clinical COVID-19 diagnostic methods: Comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR)	40
Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR	39
Torque teno virus loads after kidney transplantation predict allograft rejection but not viral infection	38
Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples	38
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.	36
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19	36
Human Calicivirus Typing tool: A web-based tool for genotyping human norovirus and sapovirus sequences	36
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay	36
Human coronaviruses: Origin, host and receptor	36
Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: The StudyCov study	35
Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection	33
Acute bronchiolitis and respiratory syncytial virus seasonal transmission during the COVID-19 pandemic in Spain: A national perspective from the pediatric Spanish Society (AEP).	33
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2	32
Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures	32
SARS-CoV-2 infection among asymptomatic healthcare workers of the emergency department in a tertiary care facility	31
Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain	31
Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants	31
Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections	31
Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design	31
Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domai	31
Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection	29
Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge	29
Correlation between monkeypox viral load and infectious virus in clinical specimens	29
RSV reemergence in Argentina since the SARS-CoV-2 pandemic	28
Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?	27
Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant	27
Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19	27
Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommen	27
Use of a simplified sample processing step without RNA extraction for direct SARS-CoV-2 RT-PCR detection	26
Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7	26
Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory	25
Evaluation and clinical validation of monkeypox (mpox) virus real-time PCR assays	25
Dynamics of IgG-avidity and antibody levels after Covid-19	25
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers	24
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests	24
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens	24
Improved oral detection is a characteristic of Omicron infection and has implications for clinical sampling and tissue tropism	24
Rapid screening method for the detection of SARS-CoV-2 variants of concern	24
Comparison of the GeneFinderTM COVID-19 Plus RealAmp Kit on the sample-to-result Platform ELITe InGenius to the national reference method: An added value of N gene target detection?	23
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection	23
Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020	22
Rapid and simultaneous identification of three mutations by the Novaplex™ SARS-CoV-2 variants I assay kit	22
Extraction-free RT-LAMP to detect SARS-CoV-2 is less sensitive but highly specific compared to standard RT-PCR in 101 samples	22
Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity	22
SARS-CoV-2 whole-genome sequencing using reverse complement PCR: For easy, fast and accurate outbreak and variant analysis.	21
Analysis of cycle threshold values in SARS-CoV-2-PCR in a long-term study	21
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)	21
Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study	21
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis	21

Accuracy and real life performance of a novel interferon-γ release assay for the detection of SARS-CoV2 specific T cell response	20
The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing	20
Validation and implementation of an orthopoxvirus qualitative real-time PCR for the diagnosis of monkeypox in the clinical laboratory	20
Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department	19
Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study	19
Human adenovirus species in children with acute respiratory illnesses	19
Comparison of SARS-CoV-2 detection from combined nasopharyngeal/oropharyngeal swab samples by a laboratory-developed real-time RT-PCR test and the Roche SARS-CoV-2 assay on a cobas 8800 instrument	18
Validation of plasma Torque Teno viral load applying a CE-certified PCR for risk stratification of rejection and infection post kidney transplantation	18
Comprehensive pathogen detection for ocular infections	18
Insights into immune evasion of human metapneumovirus: novel 180- and 111-nucleotide duplications within viral G gene throughout 2014-2017 seasons in Barcelona, Spain	18
RT-PCR based SARS-CoV-2 variant screening assays require careful quality control	18
Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virus	18
Comparison of the measured values of quantitative SARS-CoV-2 spike antibody assays	17
Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection	17
Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI)	17
Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay	17
Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients	17
CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical setting	17
Evaluation of sixteen ELISA SARS-CoV-2 serological tests	16
Highly sensitive and specific detection of the SARS-CoV-2 Delta variant by double-mismatch allele-specific real time reverse transcription PCR	16
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses	16
SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia	16
Hand, foot, and mouth disease outbreak by Coxsackievirus A6 during COVID-19 pandemic in 2021, São Paulo, Brazil.	16
Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology	15
Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting	15
Increasing prevalence of HPV in oropharyngeal carcinoma suggests adaptation of p16 screening in Southeast Asia	15
A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay	15
Human herpesvirus 6 and central nervous system disease in oncology patients: A retrospective case series and literature review	15
“The effectiveness of rapid antigen test-based for SARS-CoV-2 detection in nursing homes in Valencia, Spain”	15
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations	15
An increase in enterovirus D68 circulation and viral evolution during a period of increased influenza like illness, The Johns Hopkins Health System, USA, 2022	15
Implementation of an in-house real-time reverse transcription-PCR assay to detect the emerging SARS-CoV-2 N501Y variants	14
Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study	14
Performance of the cobas® HBV RNA automated investigational assay for the detection and quantification of circulating HBV RNA in chronic HBV patients	14
Increasing horizontal transmission of human T-cell leukemia virus type 1 in adolescents and young adults in Japan	14
Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study	14
A qualitative RT-PCR assay for the specific identification of the SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern	14
Viral metagenomic sequencing in a cohort of international travellers returning with febrile illness	14
Clinical performance and sample freeze-thaw stability of the cobas®6800 SARS-CoV-2 assay for the detection of SARS-CoV-2 in oro-/nasopharyngeal swabs and lower respiratory specimens	14
Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: May it help to predict clinical outcomes?	14
Prevalence of hepatitis E virus and its association with adverse pregnancy outcomes in pregnant women in China	14
A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG	13
Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in	13
Rapid and accurate identification of SARS-CoV-2 Omicron variants using droplet digital PCR (RT-ddPCR)	13
The circulation of Non-SARS-CoV-2 respiratory viruses and coinfections with SARS-CoV-2 during the surge of the Omicron variant	13
Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects	13
Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms	13
Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals	13
Molecular characterisation and epidemiology of enterovirus-associated aseptic meningitis in the Western and Eastern Cape Provinces, South Africa 2018–2019	12
Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department	12
Performance of saliva as a specimen to detect SARS-CoV-2	12
Universal Polymerase Chain Reaction Screening for Severe Acute Respiratory Syndrome Coronavirus 2 in Asymptomatic Patients Before Hospital Admission in Tokyo, Japan	12
Real-life evaluation of the Sofia SARS-CoV-2 antigen assay in a large tertiary care hospital	12
Comparison of anti-SARS-CoV-2 IgG and IgA antibody responses post complete vaccination, 7 months later and after 3rd dose of the BNT162b2 vaccine in healthy adults	12
Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, rand	12
Development and evaluation of an RT-qPCR for the identification of the SARS-CoV-2 Omicron variant	12
Performance of six rapid diagnostic tests for SARS-CoV-2 antigen detection and implications for practical use	12
Pooled Testing for Surveillance of SARS-CoV-2 in Asymptomatic Individuals	12
Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis	11
Natural spring water gargle and direct RT-PCR for the diagnosis of COVID-19 (COVID-SPRING study)	11
Stability of SARS-CoV-2 IgG in multiple laboratory conditions and blood sample types	11
Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL	11
Performance evaluation of the fully automated molecular system Alinity m in a high-throughput central laboratory	11
Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients	11
Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients	11
Evaluation of 16 molecular assays for the detection of orthopox and mpox viruses	11
The challenges of defining sample adequacy in an era of HPV based cervical screening	11
Rapid syndromic testing for respiratory viral infections in children attending the emergency department during COVID-19 pandemic in Lille, France, 2021–2022	11
Viral culture and immunofluorescence for the detection of SARS-CoV-2 infectivity in RT-PCR positive respiratory samples	11
A reverse-transcription droplet digital PCR assay to detect and quantify SARS-CoV-2 RNA in upper respiratory tract specimens	11
A metagenomics workflow for SARS-CoV-2 identification, co-pathogen detection, and overall diversity	11
Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial.	11
Molecular point-of-care devices for the diagnosis of infectious diseases in resource-limited settings – A review of the current landscape, technical challenges, and clinical impact	11
Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program	11
Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals	11
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2	11
A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses	10
Performance evaluation of the Viasure PCR assay for the diagnosis of monkeypox: A multicentre study	10
Comparative analysis between self-collected and clinician-collected samples for HPV testing in public health facilities in Zimbabwe	10
Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study	10

Prevalence of hepatitis delta virus among chronic hepatitis B carriers in a large tertiary center in the Netherlands	10
Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19 pandemic	10
A systematic review and meta-analysis of the accuracy of SARS-COV-2 IGM and IGG tests in individuals with COVID-19	10
Wave comparisons of clinical characteristics and outcomes of COVID-19 admissions - Exploring the impact of treatment and strain dynamics	10
Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management?	10
Drug resistance mutations in proviral DNA of HIV-infected patients with low level of viremia	10
Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia	10
Evaluation of SARS-CoV-2 total antibody detection via a lateral flow nanoparticle fluorescence immunoassay	10
A Prospective Study of Plasma and Bronchoalveolar Lavage Fluid CMV DNA Load Quantification for the Diagnosis and Outcome of CMV Pneumonitis in Immunocompromised Hosts	10
Investigation of saliva, tongue swabs and buccal swabs as alternative specimen types to nasopharyngeal swabs for SARS-CoV-2 testing	10